HHeadlines Read More Sunscreen maker at centre of recalls blocked by US regulator for yearsOctober 29, 2025 The Australian sunscreen manufacturer at the centre of a spate of recent product recalls has been blocked from…
TTop stories Read More The protein craze is heavy metal, literally: bombshell investigation finds unsafe lead amounts in two-thirds of top powders for saleOctober 17, 2025 You can never have too much of a good thing, the saying goes. For months now, Americans treated…
HHeadlines Read More Common depression drugs among those linked to autism after Trump’s bombshell Tylenol announcementOctober 5, 2025 Autism rates in the US have increased approximately 380 percent since monitoring began in 2000, with recent data…
TTop stories Read More FDA moves to allow leucovorin as treatment for autism symptomsSeptember 22, 2025 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
TTop stories Read More Covid drugmakers must ‘justify’ success after new vaccine limitsSeptember 1, 2025 U.S. President Donald Trump in the Cabinet Room of the White House on Aug. 26, 2025 in Washington,…
TTop stories Read More The FDA overhauled its COVID vaccine guidance. What it means for youAugust 29, 2025 New federal guidance surrounding COVID vaccine authorization could make it more difficult for many people to be inoculated…
TTop stories Read More FDA ends emergency use authorization for Covid vaccinesAugust 27, 2025 WASHINGTON — The Food and Drug Administration on Wednesday approved updated Covid boosters, but removed emergency use authorizations…
HHeadlines Read More Shrimp, salad kits and more: See list of FDA food recalls in 2025 so farAugust 20, 2025 The Food and Drug Administration (FDA) recently recalled frozen shrimp imported from an Indonesian firm over fears of…
HHeadlines Read More Phase 3 Trial Confirms Sarilumab Improves Polymyalgia Rheumatica OutcomesAugust 15, 2025 Vibeke Strand, MD Credit: PRIME Education New phase 3 data supported the effectiveness of sarilumab 200 mg every…
TTop stories Read More Vinay Prasad returns to the FDA, weeks after his ousterAugust 9, 2025 WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…
TTop stories Read More Vinay Prasad departs FDA | STATJuly 30, 2025 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
TTop stories Read More As Sarepta, FDA tangle over Duchenne therapy, families are caught in the middleJuly 24, 2025 Jennifer Hill Blair recognized the Cincinnati number on her buzzing phone and slipped out of the school meeting,…